>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: TSRI +45.5%, SNSS +42.3%, CVEO+11.7%, LYV +11%, ENVA +10.1%, MOBL +9.7%, SNMX +9.1%, (also discloses an extension of its collaborative research, development, commercialization and license agreement with PepsiCo), CLD +9.1%, YRCW +8.6%, BCS +8.3%,ACTG +8.1%, PXLW +7.7%, AXL +7.6%, CLUB +7.5%, GNMK +7.2%, UCTT+6.5%, MERC +6.2%, DLNG +6.1%, AVHI +5.8%, BCOV +5.7%, STMP +5.6%,SNE +5.6%, GIMO +5.5%, GIMO +5.5%, SWC +5.3%, MT +5%, PCCC +4.9%,LPLA +4.9%, XRX +4.9%, CBL +4.7%, NWL +4.3%, DECK +4%, GOOG +3.9%,VCRA +3.9%, BGS +3.7%, BBVA +3.4%, ACHC +3.2%, CATM +3.1%, UBS+3.1%, ELLI +3%, WLKP +3%, KBR +2.6%, EEP +2.5%, HTCH +2.5%, TLGT+2.3%, NSU +2.3%, ABBV +2.1%, CY +2%, AMZN +1.9%, SAVE +1.9%, CBOE+1.7%, ARII +1.4%, NLNK +1.3%, MRK +1.2%, IM +1.1%, VTR +1%, RTEC+0.9%, INVA +0.7%, PFG +0.7%, (also increases dividend ), PSX +0.7%

M&A news: PBR +1.4% (Statoil acquires 66% of Petrobras' (PBR) operated interest of the BM-S-8 offshore licence in Santos basin

Other news:
  • TERP +6.6% (light volume-TerraForm Power planning to launch a formal auction in September to sell itself, according to Bloomberg )
  • P +2.4% ( Corvex Management affirms 9.95% active stake, discloses FCC petition)
  • SHPG +1.6% (announces that the FDA has granted Fast Track designation for SHP626 for an investigational treatment of adults who have NASH with liver fibrosis)
  • GE +0.5% (following insider buy disclosure - Chairman / CEO Immelt disclosed the purchase of 50K shares at $31.45/share), .
Analyst comments:
  • TAP +1.3% (upgraded to Buy from Neutral at Citigroup)